Exclusive: Canadian drugmaker Cipher mulls sale

By Carl O’Donnell and John TilakOctober 31, 2016 – Cipher Pharmaceuticals Inc , a Canadian specialty pharmaceuticals manufacturer, has hired an investment bank to review strategic alternatives, including a potential sale, people familiar with the matter said.The strategic review comes amid…
Source: Exclusive: Canadian drugmaker Cipher mulls sale